Observational Study
Copyright ©The Author(s) 2017.
World J Diabetes. Aug 15, 2017; 8(8): 407-413
Published online Aug 15, 2017. doi: 10.4239/wjd.v8.i8.407
Table 3 Different dimensions of health related quality of life according to the clinical aspects of diabetes among diabetic people referring to diabetes clinics of Tabriz, 2015
VariableSubgroupsn (%)Physical healthSocial relationshipEnvironmentalPsychological healthTotal HRQOL
GenderMale134 (34)54.97 (12.92)41.96 (16.71)59.65 (11.14)65.26 (13.30)55.46 (11.34)
Female260 (66)49.34 (13.18)36.46 (16.48)57.88 (10.11)57.88 (14.54)50.39 (11.27)
P-value-< 0.0010.0020.115< 0.001< 0.001
Age≤ 4985 (21.6)58.65 (11.64)47.8 (17.59)61.64 (11.14)64.11 (16.15)58.8 (11.66)
59-50147 (37.3)52.36 (12.97)39.68 (15.17)59.71 (10.9)61.37 (14.71)53.28 (11.19)
≥ 60162 (41.1)46.32 (12.53)32.08 (15.02)55.68 (9.01)57.5 (12.91)47.89 (10.11)
P-value-< 0.001< 0.001< 0.0010.002< 0.001
EducationIlliterate143 (36.3)44.56 (11.04)29.8 (13.21)54.34 (8.57)55.06 (12.25)45.94 (8.73)
Primary school149 (37.8)51.99 (12.93)40.25 (16.08)57.46 (10.13)59.79 (14.31)52.37 (10.87)
Secondary school and higher102 (25.9)59.61 (11.92)47.55 (16.52)65.83 (9.7)68.77 (14.15)60.44 (10.68)
P-value-< 0.001< 0.001< 0.001< 0.001< 0.001
IncomeLow (< 1000)224 (56.8)48.43 (12.82)35.44 (17.47)56.22 (9.98)57.9 (14.73)49.50 (11.39)
acceptable170 (43.2)54.23 (13.27)41.38 (15.41)60.86 (10.49)63 (13.9)54.86 (11.06)
P-value-< 0.001< 0.001< 0.001< 0.001< 0.001
Disease duration (yr)≥ 3 yr51 (12.9)56.12 (13.81)41.88 (16.86)61.7 (12.31)65.48 (14.81)56.29 (12.18)
4-793 (23.6)51.09 (10.95)37.3 (16.15)57.52 (9.29)59.47 (12.48)51.34 (10.06)
≤ 7 yr250 (63.5)50.33 (13.89)38 (16.91)58.19 (10.43)59.7 (15.03)51.55 (11.78)
P-value-0.0190.260.0580.029< 0.001
< 2572 (20.2)55.21 (12.90)42.08 (17.32)60.77 (12.09)64.36 (15.85)55.6 (12.53)
25-29.9148 (41.6)54.2 (13.01)39.25 (15.68)59.2 (10.26)62.15 (14.22)53.7 (11.66)
≥ 30136 (38.2)47.97 (12.85)35.27 (17.46)57.16 (9.98)58.23 (13.79)49.66 (11.08)
P-value-< 0.0010.0140.0520.0080.001
HbA1c< 7180 (47.2)51.11 (12.70)38.02 (16.02)57.8 (10.84)60.1 (14.12)51.76 (11.07)
≥ 7201 (52.8)51.21 (14.01)37.96 (17.35)58.89 (10.25)60.83 (14.75)52.22 (12.05)
P-value-0.9380.9690.1360.620.696
NORMAL195 (49.6)53.83 (10.78)38.33 (15.11)60.4 (9.57)64.73 (11.81)54.32 (9.74)
Kessler psychological distressMILD72 (18.3)52.01 (13.65)41.97 (18.03)57.47 (10.25)60.84 (12.61)53.07 (11.57)
MODERATE52 (2.13)50.96 (14.41)39.19 (19.07)58.57 (12.12)59.76 (16.61)52.12 (13.91)
SEVER74 (18.8)43.9 (15.76)34.14 (17.23)54.33 (66.10)48.87 (15.22)45.31 (11.66)
P-value-< 0.0010.042< 0.001< 0.001< 0.001
Functional limitationNo106 (26.9)61.25 (10.89)47.47 (15.85)63.05 (11.16)67.91 (14.37)59.92 (10.79)
Moderate78 (19.8)54.92 (11.51)44.34 (18.16)61.12 (9.62)64.79 (12.13)56.29 (10.18)
Sever210 (53.3)44.8 (11.35)31.44 (13.25)55.17 (9.26)54.91 (13.17)46.58 (9.23)
P-value-< 0.001< 0.001< 0.001< 0.001< 0.001
TreatmentOral medication223 (57.4)53.57 (12.59)38.69 (15.71)58.97 (10.37)61.69 (14.64)53.11 (11.09)
Oral medication + insulin injection164 (42.2)48.92 (13.64)37.82 (17.96)58.07 (10.55)58.78 (14.38)50.9 (11.97)
P-value-0.0070.8830.1610.1010.12
ComorbiditiesNo102 (25.9)58.93 (11.79)42.23 (18.29)63.37 (10.57)66.51 (14.82)57.76 (11.75)
1207 (52.5)50.82 (12.07)38.28 (16.42)57.56 (10.03)60.49 (13.19)51.79 (10.66)
≥ 285 (21.6)43.05 (12.99)33.74 (14.41)54.83 (9.39)52.75 (13.88)46.09 (10.09)
P-value-< 0.0010.002< 0.001< 0.001< 0.001